Código QR (código de barras bidimensional)

Efficacy and safety of abciximab versus tirofiban in addition to ticagrelor in STEMI patients undergoing primary percutaneous intervention

Platelet glycoprotein IIb/IIIa inhibitors (GPIs) have been part of the adjuvant treatment of acute coronary syndrome for years. However, real-life data regarding the efficacy and safety of GPIs under the current indications are lacking in the setting of potent platelet inhibition. The objectives wer...

Fuld beskrivelse

Na minha lista:
Principais autores: Pablo Revilla-Martí, Jose A. Linares-Vicente, Ana Martínez Labuena, Octavio Jiménez Melo, Paula Morlanes Gracia, Daniel Meseguer González, Antonela Lukic, Borja Simó Sánchez, Jose R. Ruiz Arroyo
Format: Artigo
Sprog:Inglês
Udgivet: Taylor & Francis Group 2022-02-01
Serier:Platelets
Fag:
abciximab
percutaneous coronary intervention
platelet aggregation inhibitors
st elevation myocardial infarction
tirofiban
Online adgang:http://dx.doi.org/10.1080/09537104.2021.1881953
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker